menu
    • menu

    Company profile for CiRA Foundation

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    The CiRA Foundation is an offshoot of the Center for iPS Cell Research and Application (CiRA) and will take control of CiRA's management of iPS cells, including manufacturing and quality control, acting as a bridge for the transfer of iPS cells to industry. It was officially founded as a general incorporation foundation on September 6, 2019, but was restructured as a public interest incorporated foundation as of April 1, 2020....
    The CiRA Foundation is an offshoot of the Center for iPS Cell Research and Application (CiRA) and will take control of CiRA's management of iPS cells, including manufacturing and quality control, acting as a bridge for the transfer of iPS cells to industry. It was officially founded as a general incorporation foundation on September 6, 2019, but was restructured as a public interest incorporated foundation as of April 1, 2020. It has been more than 10 years since the first human iPS cells were reported. Now, through the hard work of researchers and cooperation of patients, iPS cell technology is being used to create new medical therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CiRA Foundationjapan Flag
    Country
    Country
    Japan
    Address
    Address
    606-8397 Kyoto, Sakyo Ward, Shogoin Kawaracho
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cira-foundation.or.jp/e/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Terumo, Cira Foundation Research Chosen For AMED Funding
    Terumo, Cira Foundation Research Chosen For AMED Funding

    05 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-05/terumo-and-cira-foundation-joint-research-selected-for-amed-funding

    PHARMIWEB
    05 Mar 2026
    Share Share
    CiRA Foundation Advances Precision Genomics
    CiRA Foundation Advances Precision Genomics

    08 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-08/one-genomics-and-cira-foundation-announce-strategic-research-collaboration-to-advance-precision-geno

    PHARMIWEB
    08 Jan 2026
    Share Share
    CiRA, Kyoto University and Astellas PII research agreement signed for iPS Cells
    CiRA, Kyoto University and Astellas PII research agreement signed for iPS Cells

    12 Apr 2023

    // INDIAN PHARMA POST

    https://www.indianpharmapost.com/news/cira-kyoto-university-and-astellas-phase-2-research-agreement-signed-for-ips-cells-13988

    INDIAN PHARMA POST
    12 Apr 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search